Market Overview

Musk Says He Ignored Analyst Questions Because They 'Represent A Short-Seller Thesis, Not Investors'

Share:
Musk Says He Ignored Analyst Questions Because They 'Represent A Short-Seller Thesis, Not Investors'
Related TSLA
Taking A Trade Break: Weak Overseas Data Center Stage Despite Solid Retail Sales
Tesla Has 'Apple-Like Consumer Brand' Potential, Wedbush Says In Bullish Initiation
Looking Through 2019 To The 2020s; 4 Major Themes (Seeking Alpha)

Tesla Inc (NASDAQ: TSLA)’s CEO can drive the stock with his enthusiasm and crush it with his ennui.

After catalyzing an 8-percent slide with dismissive remarks about Tesla’s earnings and strategy, Elon Musk defended his posture Friday.

In a series of tweets, Musk initiated a “tedious discussion about Tesla stock” where he delineated circumstances around Wednesday’s conference call.

“First, it’s important to know that Tesla is the most shorted (meaning most bet against) stock on the market & has been for a while,” he tweeted. “[...] The 2 questioners I ignored on the Q1 call are sell-side analysts who represent a short seller thesis, not investors.”

Musk reflected on two interactions that drew particular criticism.

Bernstein analyst Toni Sacconaghi Jr. was told “boring, bonehead questions are not cool” after inquiring about capital requirements, and a Model 3 reservation question from RBC’s Joseph Spak prompted a sharp and sustained shift from analyst queries to those of a retail investor.

One tweeter pushed back on the Model 3 position and requested indications for sustainable demand.

Tesla's stock closed Thursday at $284.45 per share.

Related Links:

Tesla's Q1 Earnings Recap: Per-Share Loss Better Than Expected, Model 3 Updates

With Consumer Happiness Dropping, Is Tesla In Real Trouble?

Posted-In: Elon Musk Model 3 RBC Capital Markets Toni Sacconaghi Jr.Analyst Color News Top Stories Best of Benzinga

 

Related Articles (TSLA)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
AXONJefferiesUpgrades3.0
CEQPGoldman SachsUpgrades43.0
CLXTGoldman SachsUpgrades18.0
EMRBarclaysDowngrades71.0
EQMGoldman SachsDowngrades49.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

The Market In 5 Minutes: Buffett-Apple, Activision Blizzard, Weight Watchers And More

Benzinga's Daily Biotech Pulse: Portola Receives FDA Nod, Mallinckrodt Gets Thumbs Down